Soluble drug extended release system

Details for Australian Patent Application No. 2002348279 (hide)

Owner Astellas Pharma Inc.

Inventors Kojima, Hiroyuki; Fix, Joseph A; Rogers, Victoria; Sako, Kazuhiro; Dor, Philippe J M

Agent Spruson & Ferguson

Pub. Number AU-B-2002348279

PCT Number PCT/US02/36681

PCT Pub. Number WO2003/041656

Priority 10/007,877 13.11.01 US

Filing date 12 November 2002

Wipo publication date 26 May 2003

Acceptance publication date 24 January 2008

International Classifications

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/52 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/30 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

Event Publications

13 March 2003 Complete Application Filed

  Priority application(s): 10/007,877 13.11.01 US

24 July 2003 Application Open to Public Inspection

  Published as AU-B-2002348279

12 January 2006 Change of Name(s) of Applicant(s), Section 104

  Yamanouchi Pharma Technologies, Inc.; Yamanouchi Pharmaceutical Co., Ltd The name of the applicant has been changed to Yamanouchi Pharma Technologies, Inc.; Astellas Pharma Inc.

6 December 2007 Assignment before Grant

  Astellas Pharma Inc.; Yamanouchi Pharma Technologies, Inc. The application has been assigned to Astellas Pharma Inc. Assignments before Grant, Section 113

24 January 2008 Application Accepted

  Published as AU-B-2002348279

17 April 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 01 Apr 2008. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2003

22 May 2008 Standard Patent Sealed

4 September 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 01 Apr 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002348280-Apparatus and process for generating energy

2002348278-ADJUSTABLE TOILET FLANGE ASSEMBLY